[1]单 静,贺 晶.胎母输血综合征的诊治[J].医学信息,2018,31(08):46-48.[doi:10.3969/j.issn.1006-1959.2018.08.015]
　SHAN Jing,HE Jing.Diagnosis and Treatment of Fetal Maternal Transfusion Syndrome[J].Journal of Medical Information,2018,31(08):46-48.[doi:10.3969/j.issn.1006-1959.2018.08.015]
点击复制

胎母输血综合征的诊治()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
46-48
栏目:
综述
出版日期:
2018-04-15

文章信息/Info

Title:
Diagnosis and Treatment of Fetal Maternal Transfusion Syndrome
文章编号:
1006-1959（2018）08-0046-03
作者:
单 静; 贺 晶
浙江大学医学院，浙江 杭州 310029
Author(s):
SHAN Jing; HE Jing
Medical School of Zhejiang University,Hangzhou 310029,Zhejiang,China
关键词:
胎母输血综合征; 贫血; 死胎; 围产结局
Keywords:
Key words：Fetal maternal transfusion syndrome; Anemia;  Stillbirth; Perinatal outcome
分类号:
R714.2
DOI:
10.3969/j.issn.1006-1959.2018.08.015
文献标志码:
A
摘要:
胎母输血综合征是一种罕见疾病，具有发病隐匿，临床症状不典型的特点，可导致胎儿贫血、水肿，甚至胎死宫内，临床上缺少特异性诊断方法，产前诊断困难，且临床上产科医生对该疾病的认识仍较局限。
Abstract:
Abstract：Fetal maternal transfusion syndrome is a rare disease.It has the characteristics of insidious disease and atypical clinical symptoms,which can lead to fetal anemia,edema and even fetal death.There is a lack of specific diagnostic methods and difficult prenatal diagnosis,and the clinical obstetricians' understanding of the disease is still limited.

参考文献/References:

[1]Stefanovic V.Fetomaternal hemorrhage complicated pregnancy:risks, identification, and management[J].Current Opinion in Obstetrics & Gynecology,2016,28(2):86.
[2] Stroustrup A,Plafkin C,Savitz D A.Impact of physician awareness on diagnosis of fetomaternal hemorrhage[J].Neonatology,2014,105(4):250-255.
[3]Bellussi F,Perolo A,Ghi T,et al.Diagnosis of Severe Fetomaternal Hemorrhage with Fetal Cerebral Doppler: Case Series and Systematic Review[J].Fetal Diagnosis & Therapy,2017,41(1):1-7.
[4]褚艳侠,孙统超,尹丹.胎母输血综合征的诊治[J].中国继续医学教育,2015(32):118-119.
[5] Peng H H, Ng Z P,Tang Y H,et al.Term pregnancy with choriocarcinoma presenting as severe fetal anemia and postpartum hemorrhage[J].Taiwanese Journal of Obstetrics & Gynecology,2016,55(3):430-433.
[6]O'Leary B D,Walsh C A,Fitzgerald J M,et al.The contribution of massive fetomaternal hemorrhage to antepartum stillbirth: a 25-year cross-sectional study.[J].Acta Obstetricia Et Gynecologica Scandinavica,2016,94(12):1354-1358.
[7] Ravishankar S,Migliori A,Struminsky J,et al.Placental findings in feto-maternal hemorrhage in livebirth and stillbirth[J]. Pathology - Research and Practice, 2017,213(4):301-304.
[8]Bellussi F,Perolo A,Ghi T,et al.OP08.03: Diagnosis of severe fetomaternal hemorrhage: personal experience and systematic review[J].Ultrasound in Obstetrics & Gynecology,2015,44(S1):84-85.
[9]何亚萍,乔国昱,轩维清.妊娠妇女血清中甲胎蛋白在不同孕周的发展过程及意义[J].中国误诊学杂志,2011,11(3):567-567.
[10]刘莹.联合检测母血HbF、AFP值在预测胎母输血综合征中的应用价值[J].中国医学创新,2017,14(13):44-48.
[11]Sueters M,Arabin B,Oepkes D.Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage[J].Ultrasound in Obstetrics & Gynecology the Official Journal of the International Society of Ultrasound in Obstetrics & Gynecology,2003,22(2):186-189.
[12]Liao C Y,Liao L P.Limitations of ultrasound for the diagnosis of fetomaternal hemorrhage: report of a fatal case[J].Taiwanese Journal of Obstetrics & Gynecology,2015,54(1):95-98.
[13]Stefanovic V.Fetomaternal hemorrhage complicated pregnancy: risks, identification, and management[J].Current Opinion in Obstetrics & Gynecology,2016,28(2):86.
[14]Norton M E,Chauhan S P,Dashe J S.Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis[J].American Journal of Obstetrics & Gynecology,2014,212(2):127-139.
[15]Lindenburg I T,van Kamp I L,Oepkes D.Intrauterine Blood Transfusion: Current Indications and Associated Risks.[J].Fetal Diagnosis & Therapy,2014,36(4):263-271.
[16]Hu M,Sabelman E E,Tsai C,et al.Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops.[J].Fetal Diagnosis & Therapy,2006,21(5):410-413.
[17]Sifakis S,Koukoura O,Konstantinidou A E,et al.Sonographic findings in severe fetomaternal transfusion[J].Archives of Gynecology & Obstetrics,2010,281(2):241-245.
[18]Lindenburg I T,van Klink J M,Smits-Wintjens V E,et al.Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review[J].Prenatal Diagnosis,2013,33(9):815-22.
[19]顾富贵,陈继明,刘鹤莺,等.胎母输血综合征一例[J].中华产科急救电子杂志,2016,5(1):58-59.

相似文献/References:

[1]贾鹏飞,袁 莉,赵利鹏,等.肝移植围术期EPO应用的效果及安全性研究[J].医学信息,2018,31(05):74.[doi:10.3969/j.issn.1006-1959.2018.05.024]
　JIA Peng-fei,YUAN Li,ZHAO Li-peng,et al.Study on the Effect and Safety of EPO in Perioperative Period of Liver Transplantation[J].Journal of Medical Information,2018,31(08):74.[doi:10.3969/j.issn.1006-1959.2018.05.024]
[2]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(08):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[3]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
　WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(08):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[4]张运昊.重组人促红细胞生成素治疗胃肠道恶性肿瘤化疗相关性贫血的疗效观察[J].医学信息,2019,32(08):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
　ZHANG Yun-hao.Therapeutic Effect of Recombinant Human Erythropoietin on Chemotherapy-associated Anemia of Gastrointestinal Malignant Tumor[J].Journal of Medical Information,2019,32(08):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
[5]何大海.平均红细胞血红蛋白含量对糖化血红蛋白结果的影响研究[J].医学信息,2019,32(09):85.[doi:10.3969/j.issn.1006-1959.2019.09.027]
　HE Da-hai.Effect of Mean Red Blood Cell Hemoglobin Content on Glycosylated Hemoglobin[J].Journal of Medical Information,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.09.027]
[6]黄正辉,陈小兵,刘高伦.血液透析患者贫血与超敏CRP的相关性研究[J].医学信息,2019,32(19):112.[doi:10.3969/j.issn.1006-1959.2019.19.035]
　HUANG Zheng-hui,CHEN Xiao-bing,LIU Gao-lun.Correlation Study Between Anemia and Hypersensitive C-reactive Protein in Hemodialysis Patients[J].Journal of Medical Information,2019,32(08):112.[doi:10.3969/j.issn.1006-1959.2019.19.035]
[7]李 芬,黄 丹.不同孕期孕妇贫血患病率及血清铁蛋白水平分析[J].医学信息,2019,32(23):129.[doi:10.3969/j.issn.1006-1959.2019.21.038]
　LI Fen,HUANG Dan.Analysis of Prevalence of Anemia and Serum Ferritin Levels in Pregnant Women[J].Journal of Medical Information,2019,32(08):129.[doi:10.3969/j.issn.1006-1959.2019.21.038]
[8]李光尧.重组人促红细胞生成素联合还原型谷胱甘肽对尿毒症贫血患者贫血指标及氧化应激反应的影响[J].医学信息,2023,36(19):156.[doi:10.3969/j.issn.1006-1959.2023.19.035]
　LI Guang-yao.Effect of Recombinant Human Erythropoietin Combined with Reduced Glutathione on Anemia Index and Oxidative Stress Response in Patients with Uremia Anemia[J].Journal of Medical Information,2023,36(08):156.[doi:10.3969/j.issn.1006-1959.2023.19.035]
[9]徐凯捷,欧阳桂林.加味八珍汤治疗类风湿性关节炎膝关节置换术后贫血的疗效[J].医学信息,2020,33(04):165.[doi:10.3969/j.issn.1006-1959.2020.04.055]
　XU Kai-jie,OUYANG Gui-lin.Effect of Jiawei Bazhen Decoction on Anemia after Rheumatoid Arthritis Knee Replacement[J].Journal of Medical Information,2020,33(08):165.[doi:10.3969/j.issn.1006-1959.2020.04.055]
[10]吴鑫阳,方明治.中医药治疗恶性肿瘤相关性贫血现状[J].医学信息,2020,33(06):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]
　ZHANG Zhe.Status of Treatment of Malignant Tumor-related Anemia with Traditional Chinese Medicine[J].Journal of Medical Information,2020,33(08):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]

更新日期/Last Update: 2018-04-15